Cargando…
Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?
OBJECTIVE: To assess the efficacy and clinical outcome of PGT-M undertaken on Day-3, Day-4 and Day-4 “delayed” embryos that were unsuitable for biopsy on Day-3. DESIGN AND SETTING: Cohort-historical study of all consecutive patients admitted to the IVF-PGT-M program in a large tertiary center. MAIN...
Autores principales: | Orvieto, Raoul, Feldman, Baruch, Wiesel, Marine, Shani, Hagit, Aizer, Adva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486131/ https://www.ncbi.nlm.nih.gov/pubmed/32916690 http://dx.doi.org/10.1371/journal.pone.0238599 |
Ejemplares similares
-
Can expelled cells/debris from a developing embryo be used for PGT?
por: Aizer, Adva, et al.
Publicado: (2021) -
Do human embryos have the ability of self-correction?
por: Orvieto, Raoul, et al.
Publicado: (2020) -
Future fertility of patients with zero oocytes yield in their first IVF cycle attempt
por: Orvieto, Raoul, et al.
Publicado: (2021) -
Preimplantation genetic screening- the required RCT that has not yet been carried out
por: Orvieto, Raoul
Publicado: (2016) -
Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review
por: Gleicher, Norbert, et al.
Publicado: (2017)